Funded Tech Companies
Stelexis Therapeutics
Headquartered in New York, Stelexis Therapeutics has funding from Deerfield Capital.
Company Overview
Company Name
Stelexis Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
780 3rd Ave.
New York, NY 10017
USA
New York, NY 10017
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Stelexis' mission is to become the leading cancer therapeutics company, through the discovery and development of novel drugs, utilizing its proprietary platform to selectively target pre-cancerous stem cells. The company will initially focus on therapeutics for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/9/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Doyle
Chief Scientific Officer
Keren Paz
Company Investors
- Deerfield Capital (Robert Jackson)
Browse more funded tech companies:
Stelar Tools | Stell Engineering
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs